13D

Company

INTERPACE BIOSCIENCES, INC.

Filed

July 24, 2020

Accession Number

0001783976-20-000013

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →